Guidelines & Statements
About Guidelines & Statements
The American Heart Association and American Stroke Association publish medical guidelines and scientific statements on various cardiovascular disease and stroke topics. AHA/ASA volunteer scientists and healthcare professionals write the statements. The statements are supported by scientific studies published in recognized journals and have a rigorous review and approval process. Scientific statements generally include a review of data available on a specific subject, an evaluation on its relationship to overall cardiovascular disease science, and often an AHA/ASA position on the basis of that evaluation.
Heart Disease and Stroke Statistics — 2020 UpdateThe Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health
This statement critically reviews the use of medicinal and recreational cannabis from a clinical, but also a policy and public health perspective, by evaluating its safety and efficacy profile, particularly in relationship to cardiovascular health.
Genetic Testing for Inherited Cardiovascular Diseases
This statement summarizes current best practices with respect to genetic testing and its implications for the management of inherited cardiovascular diseases.